These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972 [TBL] [Abstract][Full Text] [Related]
4. Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins. Collar AL; Clarke EC; Anaya E; Merrill D; Yarborough S; Anthony SM; Kuhn JH; Merle C; Theisen M; Bradfute SB Virology; 2017 Feb; 502():39-47. PubMed ID: 27984785 [TBL] [Abstract][Full Text] [Related]
5. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. Marzi A; Akhavan A; Simmons G; Gramberg T; Hofmann H; Bates P; Lingappa VR; Pöhlmann S J Virol; 2006 Jul; 80(13):6305-17. PubMed ID: 16775318 [TBL] [Abstract][Full Text] [Related]
6. N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion. Iraqi M; Edri A; Greenshpan Y; Kundu K; Bolel P; Cahana A; Ottolenghi A; Gazit R; Lobel L; Braiman A; Porgador A Front Cell Infect Microbiol; 2020; 10():48. PubMed ID: 32211339 [TBL] [Abstract][Full Text] [Related]
7. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. Lennemann NJ; Walkner M; Berkebile AR; Patel N; Maury W J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S204-9. PubMed ID: 26038399 [TBL] [Abstract][Full Text] [Related]
8. Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion. Bale S; Liu T; Li S; Wang Y; Abelson D; Fusco M; Woods VL; Saphire EO PLoS Negl Trop Dis; 2011 Nov; 5(11):e1395. PubMed ID: 22102923 [TBL] [Abstract][Full Text] [Related]
9. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines. Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111 [TBL] [Abstract][Full Text] [Related]
10. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. Lin G; Simmons G; Pöhlmann S; Baribaud F; Ni H; Leslie GJ; Haggarty BS; Bates P; Weissman D; Hoxie JA; Doms RW J Virol; 2003 Jan; 77(2):1337-46. PubMed ID: 12502850 [TBL] [Abstract][Full Text] [Related]
11. Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability. Maier I; Schiestl RH; Kontaxis G Molecules; 2021 Jun; 26(12):. PubMed ID: 34199200 [TBL] [Abstract][Full Text] [Related]
12. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation. Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH mBio; 2020 Sep; 11(5):. PubMed ID: 32934085 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein. Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723 [TBL] [Abstract][Full Text] [Related]
14. Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution. Beniac DR; Booth TF Sci Rep; 2017 Apr; 7():46374. PubMed ID: 28397863 [TBL] [Abstract][Full Text] [Related]
15. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus. Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743 [TBL] [Abstract][Full Text] [Related]
16. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Murin CD; Gilchuk P; Ilinykh PA; Huang K; Kuzmina N; Shen X; Bruhn JF; Bryan AL; Davidson E; Doranz BJ; Williamson LE; Copps J; Alkutkar T; Flyak AI; Bukreyev A; Crowe JE; Ward AB Cell Rep; 2021 Apr; 35(2):108984. PubMed ID: 33852862 [TBL] [Abstract][Full Text] [Related]
17. Site-specific glycosylation of Ebola virus glycoprotein by human polypeptide GalNAc-transferase 1 induces cell adhesion defects. Simon EJ; Linstedt AD J Biol Chem; 2018 Dec; 293(51):19866-19873. PubMed ID: 30389789 [TBL] [Abstract][Full Text] [Related]
18. Early steps in O-linked glycosylation and clustered O-linked glycans of herpes simplex virus type 1 glycoprotein C: effects on glycoprotein properties. Biller M; Mårdberg K; Hassan H; Clausen H; Bolmstedt A; Bergström T; Olofsson S Glycobiology; 2000 Dec; 10(12):1259-69. PubMed ID: 11159917 [TBL] [Abstract][Full Text] [Related]
19. Mechanistic understanding of Wang B; Wang Y; Frabutt DA; Zhang X; Yao X; Hu D; Zhang Z; Liu C; Zheng S; Xiang SH; Zheng YH J Biol Chem; 2017 Apr; 292(14):5860-5870. PubMed ID: 28196864 [TBL] [Abstract][Full Text] [Related]
20. Structure and Role of O-Linked Glycans in Viral Envelope Proteins. Olofsson S; Bally M; Trybala E; Bergström T Annu Rev Virol; 2023 Sep; 10(1):283-304. PubMed ID: 37285578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]